Mizolastine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

IndicationThis section has been translated automatically.

Symptomatic treatment of seasonal and perennial allergic rhinoconjunctivitis and urticaria.

Pregnancy/nursing periodThis section has been translated automatically.

Contraindicated in the 1st trimester; mizolastine should not be prescribed during pregnancy and lactation (insufficient data available).

Dosage and method of useThis section has been translated automatically.

Adults, children > 12 years.: once/day 10 mg p.o.

Undesirable effectsThis section has been translated automatically.

Gastrointestinal symptoms (diarrhoea, abdominal pain, dyspepsia, dry mouth, nausea), fatigue and tiredness, headaches, dizziness.

InteractionsThis section has been translated automatically.

Ketoconazole & Erythromycin: Moderate increase of the plasma concentration of mizolastine. Strong inhibitors or substrates of liver oxidation (cytochrome P 450 3A4), e.g. cimetidine, ciclosporin, nifedipine: slowed biotransformation and thus prolonged effect of mizolastine are possible.

PreparationsThis section has been translated automatically.

Mizollen, Zolim

Note(s)This section has been translated automatically.

Diabetics or patients with electrolyte disturbances/cardiac arrhythmia should be regularly checked during therapy.

LiteratureThis section has been translated automatically.

  1. Borchard U (2003) New H1 antihistamines in comparison. Allergology 1: 23-32

Authors

Last updated on: 29.10.2020